Keywords
lung neoplasms
pericar
Abstract
Case report. A 58-year-old woman was admitted to the Department of Internal Diseases due to resting dyspnoea, tachycardia and malaise. Her chest X-ray revealed inflammatory lesions, and empiric antibiotic therapy was initiated. Chest CT was then performed which showed lung tumours. During hospitalization, the patient suddenly developed cardiogenic shock induced by pericardial tamponade. The fluid from pericardium was subsequently collected. An histopathological examination of the fluid showed the presence of atypical cells. The patient then underwent bronchoscopy, the biopsy material of which revealed bronchial adenocarcinoma.References
1. Hanfling S.M.: Metastic cancer to the heart. Review of the literature and report of 127 cases. Circulation, 22, 474-483, 1960.
2. Fraser R.S., Viloriaa J.B., Wang N.: Cardiac tamponade as a presentation of extracardiac malignancy. Cancer, 45, 1697-1704, 1980
3. Griffith G.C.: A review of primary tumors of the heart. Prog. Cardiovasc. Dis., 7, 465, 1972.
4. Gilbert I., Henning R.J.: Adenocarcinoma of the lung presenting with pericardial tamponade: report of a case and review of the literature. Heart and Lung, 14, 83-87, 1985.
5. Pinto M.M.: Malignant pericardial effusion and cardiac tamponade. Acta Cytol., 30, 657-661, 1986.
6. Campione A. et al.: Which treatment in pericardial effusion? J. Cardiovasc. Surg., 43, 735-739, 2002.
7. Gilhert I., Henning R.J.: Adenocarcinoma of the lung presenting with pericardial tamponade: Report of a case and review of the literature. Heart Lung, 14, 83-87, 1985.
8. Muir K.W., Rodger J.C.: Cardiac tamponade as the initial presentation of malignancy: is it as rare as previously supposed? Postgrad. Med. J., 70, 703-707, 1994.
9. Haskell R.J., French W.J.: Cardiac tamponade as the initial presentation of malignancy. Chest, 88, 70-73, 1985.
10. Balghith M., Taylor D.A., Jugdutt B.I.: Cardiac tamponade as the first clinical manifestation of metastatic adenocarcinoma of the lung. Can. J. Cardiol., 16, 925-927, 2000.
11. Sobański P., Anna Adamczyk A.: Tamponada serca. Opis przypadku. Pol. Med. Paliat., 2, 1, 57-60, 2003.
12. Siniorakis E. et al.: Searching for pulsus paradoxus and correlates in cardiac tamponade. Int. J. Cardiol., 145, 127-1288, 2010.
13. Theologides A.: Neoplastic cardiac tamponade. Seniin Oncol, 5, 181-192, 1982.
14. Trusz-Gluza M. (1998). Stany zagrożenia życia pochodzenia sercowego. In: Ostre stany zagrożenia życia. Kokot F. (editor). Warszawa: PZWL.
15. Cheitlin M.D., Armstrong W.F., Aurigemma G.P.: ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines for the Clinical Application of Echocardiography. Circulation, 108-1146, 2003.
16. O’Connor C.J., Tuman K.J.: Postępowanie śródoperacyjne u chorych z tamponadą serca. Anesthesiology Clin., 28, 87-96, 2010.
17. Pasierski T., Pikto-Pietkiewicz W. (2004). Choroby osierdzia. In: Echokardiografia Hoffman P., Kasprzak J.D. (editors). Gdańsk: Wydawnictwo Via Medica; p.288-291.
18. Bodson L., Bouferrache K., Vieillard-Baron A.: Cardiac tamponade. Curr. Opin. Crit. Care, 17, 416-24, 2011.
19. Tomkowski W., Kuca P.(2005). Choroby osierdzia. In: Choroby wewnętrzne. Szczeklik A. (editor). Kraków: Medycyna praktyczna.; p.297-306.
20. Troughton R.W., Asher C.R., Klein A.L.: Pericarditis. Lancet, 363, 717-727, 2004.
21. Campione A. et al.: Which treatment in pericardial effusion? J. Cardiovasc. Surg., 43, 735-739, 2002.
22. Wang P.C. et al.: Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer. Chest, 118, 744-749, 2000.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 Unported License.
Copyright (c) 2017 Authors